ARTICLE | Clinical News
VivaGel: Feasibility study data
August 10, 2009 7:00 AM UTC
In an open-label, crossover, Australian feasibility study in 11 healthy women, CV fluid samples taken immediately after vaginal administration of VivaGel completely inhibited HIV and HSV-2 infection e...